<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">Inflammatory bowel disease</z:e> (IBD) is believed to develop via a complex interaction between genetic, environmental factors and the mucosal immune system </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> are two major clinical forms of IBD </plain></SENT>
<SENT sid="2" pm="."><plain>MicroRNAs (miRNAs) are a class of small, endogenous, noncoding <z:chebi fb="40" ids="33697">RNA</z:chebi> molecules, and evolutionary conserved in animals and plants </plain></SENT>
<SENT sid="3" pm="."><plain>It controls protein production at the post-transcriptional level by targeting <z:chebi fb="2" ids="33699">mRNAs</z:chebi> for translational repression or degradation </plain></SENT>
<SENT sid="4" pm="."><plain>MiRNAs are important in many biological processes, such as signal transduction, cellular proliferation, differentiation and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Considerable attention has been paid on the key role of miRNAs in autoimmune and <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e>, especially IBD </plain></SENT>
<SENT sid="6" pm="."><plain>Recent studies have identified altered miRNA profiles in <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e>-associated <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, emerging data have implicated that special miRNAs which suppress functional targets play a critical role in regulating key pathogenic mechanism in IBD </plain></SENT>
<SENT sid="8" pm="."><plain>MiRNAs were found involving in regulation of nuclear transcription factor kappa B pathway (e.g., miR-146a, miR-146b, miR-122, miR-132, miR-126), intestinal epithelial barrier function (e.g., miR-21, miR-150, miR-200b) and the autophagic activity (e.g., miR-30c, miR-130a, miR-106b, miR-93, miR-196) </plain></SENT>
<SENT sid="9" pm="."><plain>This review aims at discussing recent advances in our understanding of miRNAs in IBD pathogenesis, their role as disease biomarkers, and perspective for future investigation and clinical application </plain></SENT>
</text></document>